Management of patients with HIV and Hepatitis B coinfection

Carolina De La Flor, James B. Cutrell, Mamta K. Jain

Research output: Contribution to journalReview articlepeer-review


Objective: To review the literature on and provide evidence-based recommendations for management of HIV/ hepatitis B (HBV) coinfection. Methods: Review of the literature for clinical trials, guidelines, and cohort studies on HIV/HBV disease management. Results: HIV patients should be evaluated for viral hepatitis. Those who do not have evidence of immunity should be vaccinated and monitored for response. Those who have HIV/HBV should have additional serologies checked to evaluate for hepatitis B e antigen status and level of viremia. All HIV/HBV coinfected patients should be started on antiretroviral therapy with tenofovir-based regimens. Those with HIV/HBV and cirrhosis should be screened for hepatocellular cancer every 6 months. Conclusion: HIV patients should be vaccinated against hepatitis B; those with coinfection should be treated for both viruses. It is important to monitor for treatment response to both HIV and HBV and liver disease complications.

Original languageEnglish (US)
JournalJournal of Clinical Outcomes Management
Issue number10
StatePublished - Oct 1 2017


  • Dissemination
  • Implementation
  • Incentives
  • Reinforcement
  • Substance abuse treatment

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Management of patients with HIV and Hepatitis B coinfection'. Together they form a unique fingerprint.

Cite this